Nemiralisib HCl
CAS: 1254036-77-5
Ref. 3D-EAC03677
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Nemiralisib HCl is a small molecule that inhibits the activity of two proteins, PD-L1 and p-glycoprotein (Pgp), which are involved in the immune system. Nemiralisib HCl has been shown to be effective against cancer cells and inflammatory diseases. It also has pharmacokinetic properties that make it suitable for oral administration. Nemiralisib HCl binds to and inhibits lipid kinase, which is involved in the inflammatory response. Nemiralisib HCl has terminal half-life of approximately 23 hours, with an oral bioavailability of approximately 50%.
Chemical properties
Technical inquiry about: 3D-EAC03677 Nemiralisib HCl
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
